University of Chicago Medical Center ( Site 0126)

Chicago, Illinois 60637

1 studies enrolling now · 1 studies all time

What they study most

Lymphoma, Large B-Cell, Diffuse

Studies at this site

• A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011) — Recruiting now